Английская Википедия:Beractant

Материал из Онлайн справочника
Версия от 05:41, 8 февраля 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{short description|Drug for neonatal respiratory distress syndrome}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 470459211 | drug_name = | image = | alt = | caption = <!--Clinical data --> | tradename = Survanta, Alveofact | Drugs.com = {{drugs.com|monograph|beractant}} | MedlinePlus = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Beractant, also known by the trade name of Survanta, is a modified bovine pulmonary surfactant containing bovine lung extract (phospholipids, neutral lipids, fatty acids, and bovine surfactant proteins), to which synthetic DPPC, tripalmitin and palmitic acid are added. The composition provides 25 mg/mL phospholipids, 0.5 to 1.75 mg/mL triglycerides, 1.4 to 3.5 mg/mL free fatty acids, and <1.0 mg/mL total surfactant proteins.[1] As an intratracheal suspension, it can be used for the prevention and treatment of neonatal respiratory distress syndrome.[2] Survanta is manufactured by Abbvie.

Generic form

Beraksurf is generic form of Survanta (Beractant) which is manufacturing by Tekzima.

References

Шаблон:Reflist

External links

Шаблон:Portal bar


Шаблон:Respiratory-system-drug-stub